EPTIS
BAM Logo

Search a Proficiency Testing (PT) scheme in the database

Country
Page 2 of 2 (Hits 21 to 28 of 28)
ID
Country
PT provider
PT scheme
Last changed
146027 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia 2026-06-12
PT provider ID (120044)

495789 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited) [Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)] Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited) [Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)] 2026-06-12
PT provider ID (120044)

941730 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Myeloproliferative Neoplasms Diagnostic Testing (partially accredited) Myeloproliferative Neoplasms Diagnostic Testing (partially accredited) 2026-06-12
PT provider ID (120044)

146095 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Low Level Leucocyte Enumeration [Low Level Leucocyte Enumeration] Low Level Leucocyte Enumeration [Low Level Leucocyte Enumeration] 2026-06-12
PT provider ID (120044)

146015 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BCR::ABL1 and AML Translocation Identification BCR::ABL1 and AML Translocation Identification 2026-06-12
PT provider ID (120044)

146032 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Post-Stem Cell Transplant Chimerism Monitoring Post-Stem Cell Transplant Chimerism Monitoring 2026-06-12
PT provider ID (120044)

146080 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Leukaemia Diagnostic Interpretation [Leukaemia Diagnostic Interpretation ] Leukaemia Diagnostic Interpretation [Leukaemia Diagnostic Interpretation ] 2026-06-12
PT provider ID (120044)

495801 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Cerebrospinal Fluid (CSF) Immunophenotyping Cerebrospinal Fluid (CSF) Immunophenotyping 2026-06-12
PT provider ID (120044)

Page 2 of 2 (Hits 21 to 28 of 28)
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5